Author name: lsc-webmaster

THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Dyve Biosciences, Inc. today announced that longtime Pfizer Executive Chuck Harbert, Ph.D. has joined the company in the role of Chief Scientific Officer. Dr. Harbert is an acclaimed medicinal chemist and pharmaceutical industry executive with accomplishments spanning three decades with Pfizer. Dr. Harbert held a variety of leadership roles across the drug …

Dyve Biosciences Announces Chuck Harbert, Ph.D. to Join as Chief Scientific Officer Read More »

THOUSAND OAKS, Ca.–(BUSINESS WIRE)–Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed with a Phase 2 trial of DYV-700, the company’s topically administered therapeutic being developed to reduce the pain and duration of an acute gout flare. Dyve intends to initiate the Phase 2 trial, …

Dyve Biosciences Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for Treatment of Acute Gout Pain Read More »

THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Dyve Bioscience, a biotech drug delivery company developing novel transdermal technologies for delivery of molecules through the skin, announced positive results from a human proof-of-concept pilot study of transdermal sodium bicarbonate for reducing pain associated with an acute gout flare. “Our mission is to change the standard of care for people suffering …

Dyve Biosciences Announces Positive Results from Pilot Study in Gout Pain at European Crystal Network Workshop 2019 Read More »